2021
DOI: 10.1055/s-0041-1730445
|View full text |Cite
|
Sign up to set email alerts
|

Spasmodic Abdominal Pain and Other Gastrointestinal Symptoms in Pontocerebellar Hypoplasia Type 2

Abstract: Introduction Pontocerebellar hypoplasia type 2 (PCH2) is a rare neurodevelopmental disease with a high disease burden. Besides neurological symptoms, somatic symptoms, such as gastroesophageal reflux (GERD) and failure to thrive, are major contributors to this burden. Methods We report three patients with genetically confirmed PCH2A and significant gastrointestinal (GI) symptoms. Results Apart from impaired swallowing and GERD, which are frequently reported in patients with PCH2, all three … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…PCH2A is a rare neurodevelopmental disorder accompanied by severe gastrointestinal symptoms, dysphagia and feeding problems (30, 31). Patients with PCH2A often fail to thrive, despite PEG-placement in many of the affected patients (5).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…PCH2A is a rare neurodevelopmental disorder accompanied by severe gastrointestinal symptoms, dysphagia and feeding problems (30, 31). Patients with PCH2A often fail to thrive, despite PEG-placement in many of the affected patients (5).…”
Section: Discussionmentioning
confidence: 99%
“…To calculate PCH2A-specific growth charts, we included retrospective data of a predominantly German cohort of 65 patients with genetically proven PCH2A age 0-18 years, and applied data of a German reference population (KiGGS) as basis for comparison (14,15). PCH2A is a rare neurodevelopmental disorder accompanied by severe gastrointestinal symptoms, dysphagia and feeding problems (30,31). Patients with PCH2A often fail to thrive, despite PEGplacement in many of the affected patients (5).…”
Section: Discussionmentioning
confidence: 99%